Cite
MLA Citation
J.B. Auliac et al.. “Corrigendum to "Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study" [Lung Cancer 85 (2014) 415–419].” Lung cancer, vol. 87, no. 2, n.d., pp. 210–. http://access.bl.uk/ark:/81055/vdc_100050954871.0x00004c